tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Consun Pharmaceutical Group to Discuss New Share Award Scheme and Amendments

Story Highlights
  • Consun Pharmaceutical plans to introduce a share award scheme for issuing up to 84,281,191 shares.
  • The company seeks to amend its memorandum and articles to align with strategic goals.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Consun Pharmaceutical Group to Discuss New Share Award Scheme and Amendments

TipRanks Cyber Monday Sale

An announcement from Consun Pharmaceutical Group Ltd. ( (HK:1681) ) is now available.

Consun Pharmaceutical Group Limited has announced an extraordinary general meeting to discuss and potentially approve a new share award scheme. This scheme aims to issue up to 84,281,191 shares to eligible participants, including a sublimit of 8,428,119 shares for service providers. Additionally, the company plans to amend its memorandum and articles of association to better align with its strategic goals.

The most recent analyst rating on (HK:1681) stock is a Buy with a HK$17.00 price target. To see the full list of analyst forecasts on Consun Pharmaceutical Group Ltd. stock, see the HK:1681 Stock Forecast page.

More about Consun Pharmaceutical Group Ltd.

YTD Price Performance: 89.60%

Average Trading Volume: 2,923,195

Technical Sentiment Signal: Buy

Current Market Cap: HK$12.2B

For an in-depth examination of 1681 stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1